A detailed history of Group One Trading, L.P. transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 3,457 shares of OMGA stock, worth $2,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,457
Previous 3,457 -0.0%
Holding current value
$2,731
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.86 - $3.2 $2,976 - $5,120
-1,600 Reduced 31.64%
3,457 $7,000
Q1 2024

May 10, 2024

BUY
$2.73 - $5.32 $9,983 - $19,455
3,657 Added 261.21%
5,057 $18,000
Q4 2023

Feb 14, 2024

SELL
$1.35 - $3.21 $1,705 - $4,054
-1,263 Reduced 47.43%
1,400 $4,000
Q3 2023

Nov 09, 2023

BUY
$2.15 - $5.68 $5,725 - $15,125
2,663 New
2,663 $5,000
Q1 2023

May 12, 2023

BUY
$4.81 - $10.95 $9,620 - $21,900
2,000 New
2,000 $12,000

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $37.8M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.